Brødkrumme Forside Vesper Biotechnology Vesper Biotechnology Vesper Technology is a preclinical biotech company developing treatments based on Vps10p-protein to target various therapeutic indications. Related news about Vesper Biotechnology Lundbeck Foundation doubles its investment in Aarhus-based Insusense Therapeutics Lundbeckfonden BioCapital Investeringsår 2012 Seed Financing Lokation Aarhus, Denmark Investors Lundbeckfonden BioCapital Kontakt Paul Little Operating Partner pl@lundbeckfonden.com
